Nutriband Inc.


5.36 (USD) • At close June 14, 2024
Bedrijfsnaam Nutriband Inc.
Symbool NTRB
Munteenheid USD
Prijs 5.36
Beurswaarde 59,153,496
Dividendpercentage 0%
52-weken bereik 1.53 - 6.75
Industrie Biotechnology
Sector Healthcare
CEO Mr. Gareth Sheridan

An error occurred while fetching data.

Over Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops

Vergelijkbare Aandelen

Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc.


50.1 USD

Oncternal Therapeutics, Inc. logo

Oncternal Therapeutics, Inc.


8.784 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.


1.02 USD

Biomerica, Inc. logo

Biomerica, Inc.


0.577 USD

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.


8.2 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)